Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Epidemiol ; 38(6): 699-711, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-37169991

RESUMO

The Tehran cardiometabolic genetic study (TCGS) is a large population-based cohort study that conducts periodic follow-ups. TCGS has created a comprehensive database comprising 20,367 participants born between 1911 and 2015 selected from four main ongoing studies in a family-based longitudinal framework. The study's primary goal is to identify the potential targets for prevention and intervention for non-communicable diseases that may develop in mid-life and late life. TCGS cohort focuses on cardiovascular, endocrine, metabolic abnormalities, cancers, and some inherited diseases. Since 2017, the TCGS cohort has augmented by encoding all health-related complications, including hospitalization outcomes and self-reports according to ICD11 coding, and verifying consanguineous marriage using genetic markers. This research provides an update on the rationale and design of the study, summarizes its findings, and outlines the objectives for precision medicine.


Assuntos
Doenças Cardiovasculares , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/genética , Doenças Cardiovasculares/prevenção & controle , Irã (Geográfico)/epidemiologia , Estudos Longitudinais , Estudos de Coortes
2.
Sci Rep ; 11(1): 10305, 2021 05 13.
Artigo em Inglês | MEDLINE | ID: mdl-33986338

RESUMO

Metabolic syndrome (MetS) is one of the most important risk factors for cardiovascular disease. The 11p23.3 chromosomal region plays a potential role in the pathogenesis of MetS. The present study aimed to assess the association between 18 single nucleotide polymorphisms (SNPs) located at the BUD13, ZPR1, and APOA5 genes with MetS in the Tehran Cardio-metabolic Genetics Study (TCGS). In 5421 MetS affected and non-affected participants, we analyzed the data using two models. The first model (MetS model) examined SNPs' association with MetS. The second model (HTg-MetS Model) examined the association of SNPs with MetS affection participants who had a high plasma triglyceride (TG). The four-gamete rules were used to make SNP sets from correlated nearby SNPs. The kernel machine regression models and single SNP regression evaluated the association between SNP sets and MetS. The kernel machine results showed two sets over three sets of correlated SNPs have a significant joint effect on both models (p < 0.0001). Also, single SNP regression results showed that the odds ratios (ORs) for both models are almost similar; however, the p-values had slightly higher significance levels in the HTg-MetS model. The strongest ORs in the HTg-MetS model belonged to the G allele in rs2266788 (MetS: OR = 1.3, p = 3.6 × 10-7; HTg-MetS: OR = 1.4, p = 2.3 × 10-11) and the T allele in rs651821 (MetS: OR = 1.3, p = 2.8 × 10-7; HTg-MetS: OR = 1.4, p = 3.6 × 10-11). In the present study, the kernel machine regression models could help assess the association between the BUD13, ZPR1, and APOA5 gene variants (11p23.3 region) with lipid-related traits in MetS and MetS affected with high TG.


Assuntos
Apolipoproteína A-V/genética , Predisposição Genética para Doença , Aprendizado de Máquina , Proteínas de Membrana Transportadoras/genética , Síndrome Metabólica/genética , Polimorfismo de Nucleotídeo Único , Proteínas de Ligação a RNA/genética , Fatores de Risco Cardiometabólico , Feminino , Humanos , Irã (Geográfico) , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA